Literature DB >> 19029401

Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer.

Kiersten S Derby1, Kristine Cuthrell, Christian Caberto, Steven G Carmella, Adrian A Franke, Stephen S Hecht, Sharon E Murphy, Loïc Le Marchand.   

Abstract

Previously, we documented that smoking-associated lung cancer risk is greater in Hawaiians and lower in Japanese compared with Whites. Nicotine metabolism by cytochrome P450 2A6 (CYP2A6) varies across ethnicity/race and is hypothesized to affect smoking behavior. We investigated whether higher CYP2A6 activity results in the smoker extracting more nicotine (adjusting for cigarettes per day) and being exposed to higher levels of tobacco-specific nitrosamine [4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)] and pyrene, a representative polycyclic aromatic hydrocarbon. We conducted a cross-sectional study of 585 smokers among the three main ethnic/racial groups in Hawaii and examined whether differences in CYP2A6 activity correlate with the ethnic/racial differences in lung cancer risk. We assessed CYP2A6 activity by nicotine metabolite ratio (total trans-3-hydroxycotinine/total cotinine) and caffeine metabolite ratio (1,7-dimethyl uric acid/1,7-dimethylxanthine) in 12 h urine. We also measured urinary nicotine equivalents (sum of nicotine, cotinine, and trans-3-hydroxycotinine and their respective glucuronides), a marker of nicotine dose, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronide, markers of NNK exposure, and 1-hydroxypyrene, a marker of pyrene exposure. The nicotine metabolite ratio was higher in Whites than in Japanese and intermediate in Hawaiians (P values < 0.05). Cigarettes per day-adjusted nicotine equivalents were lower in Japanese compared with Hawaiians or Whites (P = 0.005 and P < 0.0001, respectively) and greater in men than women (P < 0.0001). Nicotine equivalents and total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol increased with CYP2A6 activity, indicating that smokers with greater nicotine metabolism smoke more extensively and have a higher internal NNK dose. The particularly low nicotine metabolism of Japanese smokers may contribute to their previously described decreased lung cancer risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029401      PMCID: PMC2599805          DOI: 10.1158/1055-9965.EPI-08-0424

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  47 in total

1.  Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany.

Authors:  Gerhard Scherer; Johannes Engl; Michael Urban; Gerhard Gilch; Dinamis Janket; Kirsten Riedel
Journal:  Regul Toxicol Pharmacol       Date:  2006-10-10       Impact factor: 3.271

2.  Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry.

Authors:  Peyton Jacob; Margaret Wilson; Neal L Benowitz
Journal:  Anal Chem       Date:  2007-01-15       Impact factor: 6.986

3.  CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals.

Authors:  P V Nerurkar; L Okinaka; C Aoki; A Seifried; A Lum-Jones; L R Wilkens; L Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-10       Impact factor: 4.254

4.  Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.

Authors:  Miki Nakajima; Tatsuki Fukami; Hiroyuki Yamanaka; Eriko Higashi; Haruko Sakai; Ryoko Yoshida; Jun-Tack Kwon; Howard L McLeod; Tsuyoshi Yokoi
Journal:  Clin Pharmacol Ther       Date:  2006-09       Impact factor: 6.875

5.  Effects of dietary broccoli on human in vivo caffeine metabolism: a pilot study on a group of Jordanian volunteers.

Authors:  Nancy Hakooz; Imad Hamdan
Journal:  Curr Drug Metab       Date:  2007-01       Impact factor: 3.731

6.  Urine nicotine metabolites and smoking behavior in a multiracial/multiethnic national sample of young adults.

Authors:  Denise B Kandel; Mei-Chen Hu; Christine Schaffran; J Richard Udry; Neal L Benowitz
Journal:  Am J Epidemiol       Date:  2007-02-23       Impact factor: 4.897

7.  Female sex and oral contraceptive use accelerate nicotine metabolism.

Authors:  Neal L Benowitz; Christina N Lessov-Schlaggar; Gary E Swan; Peyton Jacob
Journal:  Clin Pharmacol Ther       Date:  2006-05       Impact factor: 6.875

8.  A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics.

Authors:  L N Kolonel; B E Henderson; J H Hankin; A M Nomura; L R Wilkens; M C Pike; D O Stram; K R Monroe; M E Earle; F S Nagamine
Journal:  Am J Epidemiol       Date:  2000-02-15       Impact factor: 4.897

9.  Human CYP2A6 is induced by estrogen via estrogen receptor.

Authors:  Eriko Higashi; Tatsuki Fukami; Masahiro Itoh; Satoru Kyo; Masaki Inoue; Tsuyoshi Yokoi; Miki Nakajima
Journal:  Drug Metab Dispos       Date:  2007-07-23       Impact factor: 3.922

10.  Smoking and colorectal cancer: different effects by type of cigarettes?

Authors:  Margreet Lüchtenborg; Kami K L White; Lynne Wilkens; Laurence N Kolonel; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-07       Impact factor: 4.254

View more
  61 in total

1.  1,3-Butadiene exposure and metabolism among Japanese American, Native Hawaiian, and White smokers.

Authors:  Sungshim Lani Park; Srikanth Kotapati; Lynne R Wilkens; Maarit Tiirikainen; Sharon E Murphy; Natalia Tretyakova; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11       Impact factor: 4.254

2.  Relationship between amounts of daily cigarette consumption and abdominal obesity moderated by CYP2A6 genotypes in Chinese male current smokers.

Authors:  Tao Liu; Sean P David; Rachel F Tyndale; Hui Wang; Xue-Qing Yu; Wei Chen; Qian Zhou; Wei-Qing Chen
Journal:  Ann Behav Med       Date:  2012-04

3.  UGT2B10 genotype influences nicotine glucuronidation, oxidation, and consumption.

Authors:  Jeannette Zinggeler Berg; Linda B von Weymarn; Elizabeth A Thompson; Katherine M Wickham; Natalie A Weisensel; Dorothy K Hatsukami; Sharon E Murphy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

Review 4.  Nicotine reduction revisited: science and future directions.

Authors:  Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

5.  A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine.

Authors:  Taraneh Taghavi; Maria Novalen; Caryn Lerman; Tony P George; Rachel F Tyndale
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-05-31       Impact factor: 4.254

6.  Informed genome-wide association analysis with family history as a secondary phenotype identifies novel loci of lung cancer.

Authors:  Julia G Poirier; Paul Brennan; James D McKay; Margaret R Spitz; Heike Bickeböller; Angela Risch; Geoffrey Liu; Loic Le Marchand; Shelley Tworoger; John McLaughlin; Albert Rosenberger; Joachim Heinrich; Irene Brüske; Thomas Muley; Brian E Henderson; Lynne R Wilkens; Xuchen Zong; Yafang Li; Ke Hao; Wim Timens; Yohan Bossé; Don D Sin; Ma'en Obeidat; Christopher I Amos; Rayjean J Hung
Journal:  Genet Epidemiol       Date:  2015-01-19       Impact factor: 2.135

7.  Cigarette consumption and biomarkers of nicotine exposure during pregnancy and postpartum.

Authors:  Taraneh Taghavi; Christopher A Arger; Sarah H Heil; Stephen T Higgins; Rachel F Tyndale
Journal:  Addiction       Date:  2018-07-23       Impact factor: 6.526

8.  CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study.

Authors:  Jian-Min Yuan; Heather H Nelson; Steven G Carmella; Renwei Wang; Jacquelyn Kuriger-Laber; Aizhen Jin; Jennifer Adams-Haduch; Stephen S Hecht; Woon-Puay Koh; Sharon E Murphy
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

9.  Nicotine Metabolism in Young Adult Daily Menthol and Nonmenthol Smokers.

Authors:  Pebbles Fagan; Pallav Pokhrel; Thaddeus A Herzog; Ian S Pagano; Adrian A Franke; Mark S Clanton; Linda A Alexander; Dennis R Trinidad; Kari-Lyn K Sakuma; Carl A Johnson; Eric T Moolchan
Journal:  Nicotine Tob Res       Date:  2015-05-19       Impact factor: 4.244

10.  Nicotine metabolism in African Americans and European Americans: variation in glucuronidation by ethnicity and UGT2B10 haplotype.

Authors:  Jeannette Zinggeler Berg; Jesse Mason; Angela J Boettcher; Dorothy K Hatsukami; Sharon E Murphy
Journal:  J Pharmacol Exp Ther       Date:  2009-09-28       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.